Collectively, our findings suggest that extensive loss of N-glycan structures on FH during SP-HUS episodes does not affect its canonical complement-regulatory function and that specific FH deglycosylation on itself is unlikely to contribute to disease pathogenesis through dysregulation of the AP. This evidence concerns the gene FH and hemolytic-uremic syndrome.